Got Stock?
Results 1 - 10 of 66 : 1 2 3 4 5 6 7 Next
Has Momenta Pharmaceuticals Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
Biosimilars: Big Pharma's Next Big Thing?
The Food and Drug Administration opens the floodgates to the manufacture of generic equivalents of biotech drugs.
All Good Things Must Come to an End
Momenta will go back to its losing ways.
5 of Last Week's Biggest Losers
These five stocks only made shorts some serious money last week.
The Week's Biggest Stock Laggards
It was a relatively lackluster week for the market, but some stocks lagged way behind the rest.
Here's How Momenta Pharmaceuticals Is Making You So Much Cash
All cash flow is not created equal.
You've Got 4 Days Left to Do This
Roth conversions for 2011 expire Dec. 31.
The Next Trend in Biotech Partnerships
Biosimilar development partnerships are popping up everywhere.
The Best ETF for 2012: SPDR S&P Biotech
Why choose one or two promising stocks when you can buy a big bunch?
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK